Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders

Bibliographic Details
Main Authors:	S Oertle, H Mauron, PN Villiger
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2002-07-01
Series:	Swiss Medical Weekly
Subjects:	etanercept Infliximab Cogan syndrome Behcet's disease Wegener's disease rheumatoid arthritis
Online Access:	https://www.smw.ch/index.php/smw/article/view/197

Internet